Comparative Expression Analysis of the Antagonistic Transcription Factors EVI1 and MDS1-EVI1 in Murine Tissues and duringin VitroHematopoietic Differentiation

This publication has 18 references indexed in Scilit:

• The EVI1 gene in myeloid leukemia
  Leukemia, 1997
• Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
  Proceedings of the National Academy of Sciences, 1996
• Zinc Fingers 1–7 of EVI1 Fail to Bind to the GATA Motif by Itself but Require the Core Site GACAAGATA for Binding
  Journal of Biological Chemistry, 1996
• Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations
  Blood, 1994
• Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations.
  Proceedings of the National Academy of Sciences, 1994
• DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome
  Blood, 1994
• Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene.
  Proceedings of the National Academy of Sciences, 1993
• Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.
  Proceedings of the National Academy of Sciences, 1992
• Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor.
  Molecular and Cellular Biology, 1992
• Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines
  Cell, 1988